Literature DB >> 25413568

The associations between the MCP-1 -2518 A/G polymorphism and ischemic heart disease and ischemic stroke: a meta-analysis of 28 research studies involving 21,524 individuals.

Gaojun Cai1, Bifeng Zhang, Weijin Weng, Ganwei Shi, Zhiying Huang.   

Abstract

Epidemiologic studies have been performed to explore the relationship between MCP-1 polymorphism and ischemic heart disease (IHD) and ischemic stroke (IS). But, the results are not consistent. Because of the poor effect of each individual study, we've performed a systematic review and a meta-analysis. A comprehensive search was carried out from PubMed, Embase, Foreign Medical Journal Service (FMJS), China National Knowledge Infrastructure and Wanfang Data. Odds ratios (OR) with 95% confidence interval (CI) were used to evaluate the strength of associations between the MCP-1 A-2518G polymorphism (rs1024611) and IHD and IS susceptibilities. The pooled OR was calculated by the allelic model (G vs A), the additive model (GG vs AA), the dominant model (GG+GA vs AA) and the recessive model (GG vs AA+GA), respectively. The homogeneity among studies was checked using Cochrane Q statistic. The stability of results was checked by one-way sensitivity analysis. The publication bias between studies was examined by Begg's funnel plots and Egger's test. 28 eligible case-control studies met all the criteria and were involved in the present meta-analysis, including a total of 8,901 cases and 12,623 controls. Overall, the MCP-1 A-2518G polymorphism was significantly associated with the IHD susceptibility. The pooled OR was 1.27 (95% CI 1.09-1.48, P = 0.002) in the dominant model, 1.20 (95% CI 1.07-1.35, P = 0.001) in the allelic model, 1.25 (95% CI 1.05-1.50, P = 0.015) in the recessive model and 1.39 (95% CI 1.10-1.75, P = 0.005) in the additive model. At the same time, the MCP-1 A-2518G polymorphism was significantly associated with the IS susceptibility. The pooled OR was 1.72 (95% CI 1.12-2.65, P = 0.013) in the dominant model, 1.39 (95% CI 1.12-1.74, P = 0.003) in the allelic model, 1.59 (95% CI 1.30-1.93, P = 0.000) in the recessive model, and 2.33 (95% CI 1.76-3.08, P = 0.000) in the additive model, respectively. No significant publication bias was found in the present meta-analysis. The results of the present meta-analysis suggest that MCP-1 gene A-2518G polymorphism may be associated with the IHD and IS susceptibilities. But the positive result exists in relatively small sample size subgroup.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25413568     DOI: 10.1007/s11033-014-3836-8

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  34 in total

1.  Chemokine ligand 2 genetic variants, serum monocyte chemoattractant protein-1 levels, and the risk of coronary artery disease.

Authors:  Diederik F van Wijk; Sander I van Leuven; Manjinder S Sandhu; Michael W Tanck; Barbara A Hutten; Nicholas J Wareham; John J P Kastelein; Erik S G Stroes; Kay-Tee Khaw; S Matthijs Boekholdt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-04-29       Impact factor: 8.311

2.  Assessment of genetic effects of polymorphisms in the MCP-1 gene on serum MCP-1 levels and myocardial infarction in Japanese.

Authors:  Naoharu Iwai; Kazuaki Kajimoto; Yoshihiro Kokubo; Akira Okayama; Shunichi Miyazaki; Hiroshi Nonogi; Yoichi Goto; Hitonobu Tomoike
Journal:  Circ J       Date:  2006-07       Impact factor: 2.993

3.  A monocyte chemoattractant protein-1 gene polymorphism is associated with occult ischemia in a high-risk asymptomatic population.

Authors:  Min P Kim; Larry M Wahl; Lisa R Yanek; Diane M Becker; Lewis C Becker
Journal:  Atherosclerosis       Date:  2006-08-24       Impact factor: 5.162

4.  Examination of genetic effects of polymorphisms in the MCP-1 and CCR2 genes on MI in the Icelandic population.

Authors:  Kristjana Bjarnadottir; Gudny Eiriksdottir; Thor Aspelund; Vilmundur Gudnason
Journal:  Atherosclerosis       Date:  2005-12-13       Impact factor: 5.162

5.  Impact of MCP-1 and CCR-2 gene polymorphisms on coronary artery disease susceptibility.

Authors:  Hsiu-Ling Lin; Kwo-Chang Ueng; Yih-Shou Hsieh; Whei-Ling Chiang; Shun-Fa Yang; Shu-Chen Chu
Journal:  Mol Biol Rep       Date:  2012-07-03       Impact factor: 2.316

6.  Monocyte chemoattractant protein-1 in human atheromatous plaques.

Authors:  N A Nelken; S R Coughlin; D Gordon; J N Wilcox
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

7.  Genetic polymorphism in the pregnancy-associated plasma protein-A associated with acute myocardial infarction.

Authors:  Sungha Park; Jong-Chan Youn; Dong-Jik Shin; Chan-Mi Park; Jung-Sun Kim; Young-Guk Ko; Donghoon Choi; Jong-Won Ha; Yangsoo Jang; Namsik Chung
Journal:  Coron Artery Dis       Date:  2007-09       Impact factor: 1.439

8.  Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for cardiovascular disease in hemodialyzed patients.

Authors:  Monika Buraczynska; Anna Bednarek-Skublewska; Kinga Buraczynska; Andrzej Ksiazek
Journal:  Cytokine       Date:  2008-11-17       Impact factor: 3.861

9.  Proinflammatory genetic profiles in subjects with history of ischemic stroke.

Authors:  Andrea Flex; Eleonora Gaetani; Pierangelo Papaleo; Giuseppe Straface; Anna S Proia; Giovanni Pecorini; Paolo Tondi; Paolo Pola; Roberto Pola
Journal:  Stroke       Date:  2004-08-12       Impact factor: 7.914

10.  Effect of monocyte chemoattractant protein-1 (MCP-1) gene polymorphism in Turkish patients with premature coronary artery disease.

Authors:  Sirri F Cam; Cevad Sekuri; Abdi Sagcan; Ertugrul Ercan; Istemihan Tengiz; Emin Alioglu; Afig Berdeli
Journal:  Scand J Clin Lab Invest       Date:  2008       Impact factor: 1.713

View more
  10 in total

1.  Clinical impact of echocardiography parameters and molecular biomarkers in heart failure: Correlation of ACE2 and MCP-1 polymorphisms with echocardiography parameters: A comparative study.

Authors:  Mălina Suciu-Petrescu; Anamaria Truta; Mihai Domnutiu Suciu; Adrian Pavel Trifa; Denisa Petrescu; Horia Ștefan Roșianu; Octavia Sabin; Daciana Elena Popa; Antonia Eugenia Macarie; Ștefan Cristian Vesa; Anca Dana Buzoianu
Journal:  Exp Ther Med       Date:  2021-04-28       Impact factor: 2.447

2.  Neutrophil Extracellular Traps Induce MCP-1 at the Culprit Site in ST-Segment Elevation Myocardial Infarction.

Authors:  Thomas M Hofbauer; Anna S Ondracek; Andreas Mangold; Thomas Scherz; Johanna Nechvile; Veronika Seidl; Christine Brostjan; Irene M Lang
Journal:  Front Cell Dev Biol       Date:  2020-11-09

3.  Berberine inhibits the ischemia-reperfusion injury induced inflammatory response and apoptosis of myocardial cells through the phosphoinositide 3-kinase/RAC-α serine/threonine-protein kinase and nuclear factor-κB signaling pathways.

Authors:  Lixin Wang; Hao Ma; Yan Xue; Haiyan Shi; Teng Ma; Xiaozheng Cui
Journal:  Exp Ther Med       Date:  2017-11-27       Impact factor: 2.447

4.  Associations of estradiol levels and genetic polymorphisms of inflammatory genes with the risk of ischemic stroke.

Authors:  Yi-Chen Hsieh; Fang-I Hsieh; Yih-Ru Chen; Chaur-Jong Hu; Jiann-Shing Jeng; Sung-Chun Tang; Nai-Fang Chi; Huey-Juan Lin; Li-Ming Lien; Giia-Sheun Peng; Hung-Yi Chiou
Journal:  J Biomed Sci       Date:  2017-03-28       Impact factor: 8.410

5.  Physical activity initiated by employer induces improvements in a novel set of biomarkers of inflammation: an 8-week follow-up study.

Authors:  Lars-Kristian Lunde; Øivind Skare; Hans C D Aass; Asgeir Mamen; Elín Einarsdóttir; Bente Ulvestad; Marit Skogstad
Journal:  Eur J Appl Physiol       Date:  2017-02-09       Impact factor: 3.078

6.  Conserved regulatory logic at accessible and inaccessible chromatin during the acute inflammatory response in mammals.

Authors:  Azad Alizada; Nadiya Khyzha; Liangxi Wang; Lina Antounians; Xiaoting Chen; Melvin Khor; Minggao Liang; Kumaragurubaran Rathnakumar; Matthew T Weirauch; Alejandra Medina-Rivera; Jason E Fish; Michael D Wilson
Journal:  Nat Commun       Date:  2021-01-25       Impact factor: 14.919

Review 7.  The Role of CCL2/CCR2 Axis in Cerebral Ischemia-Reperfusion Injury and Treatment: From Animal Experiments to Clinical Trials.

Authors:  Huixia Geng; Luna Chen; Jing Tang; Yi'ang Chen; Lai Wang
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

8.  The Relationship Between Chemokine and Chemokine Receptor Genes Polymorphisms and Chronic Obstructive Pulmonary Disease Susceptibility in Tatar Population from Russia: A Case Control Study.

Authors:  Gulnaz F Korytina; Yulia G Aznabaeva; Leysan Z Akhmadishina; Olga V Kochetova; Timur R Nasibullin; Naufal Sh Zagidullin; Shamil Z Zagidullin; Tatyana V Viktorova
Journal:  Biochem Genet       Date:  2021-06-06       Impact factor: 1.890

9.  Association between kidney function and genetic polymorphisms in atherosclerotic and chronic kidney diseases: A cross-sectional study in Japanese male workers.

Authors:  Yoko Kubo; Takahiro Imaizumi; Masahiko Ando; Masahiro Nakatochi; Yoshinari Yasuda; Hiroyuki Honda; Yachiyo Kuwatsuka; Sawako Kato; Kyoko Kikuchi; Takaaki Kondo; Masamitsu Iwata; Toru Nakashima; Hiroshi Yasui; Hideki Takamatsu; Hiroshi Okajima; Yasuko Yoshida; Shoichi Maruyama
Journal:  PLoS One       Date:  2017-10-10       Impact factor: 3.240

10.  Association between CTSS gene polymorphism and the risk of acute atherosclerotic cerebral infarction in Chinese population: a case-control study.

Authors:  Lian Luo; Mingli Zhu; Jiajun Zhou
Journal:  Biosci Rep       Date:  2018-11-20       Impact factor: 3.840

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.